PROCHLORPERAZINE EDISYLATE - Generic Drug Details

What are the generic sources for prochlorperazine edisylate and what is the scope of freedom to operate?

Prochlorperazine edisylate is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Alpharma Us Pharms, Morton Grove, Baxter Hlthcare, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Teva Parenteral, Viwit Pharm, Watson Labs, and Wyeth Ayerst, and is included in twenty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for prochlorperazine edisylate. Sixteen suppliers are listed for this compound.

Summary for PROCHLORPERAZINE EDISYLATE

US Patents:	0
Tradenames:	3
Applicants:	20
NDAs:	28
Drug Master File Entries:	9
Finished Product Suppliers / Packagers:	16
Raw Ingredient (Bulk) Api Vendors:	35
Patent Applications:	513
What excipients (inactive ingredients) are in PROCHLORPERAZINE EDISYLATE?	PROCHLORPERAZINE EDISYLATE excipients list
DailyMed Link:	PROCHLORPERAZINE EDISYLATE at DailyMed

Pharmacology for PROCHLORPERAZINE EDISYLATE

Drug Class

Phenothiazine

US Patents and Regulatory Information for PROCHLORPERAZINE EDISYLATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Parenteral	PROCHLORPERAZINE EDISYLATE	prochlorperazine edisylate	INJECTABLE;INJECTION	040505-001	May 30, 2003		DISCN	No	No
Gland Pharma Ltd	PROCHLORPERAZINE EDISYLATE	prochlorperazine edisylate	INJECTABLE;INJECTION	214107-001	Sep 22, 2021	AP	RX	No	No
Hospira	PROCHLORPERAZINE EDISYLATE	prochlorperazine edisylate	INJECTABLE;INJECTION	089703-001	Apr 7, 1988		DISCN	No	No
Caplin	PROCHLORPERAZINE EDISYLATE	prochlorperazine edisylate	INJECTABLE;INJECTION	214379-001	Apr 22, 2021	AP	RX	No	No